Author

Michelle Fan-Port

OpenAlex ID: A5005780809

Next generation sequencing (NGS) to identify relapsed gastrointestinal (GI) solid tumor patients with human leukocyte antigen (HLA) loss of heterozygosity (LOH) for future logic-gated CAR T therapy to reduce on target off tumor toxicity.

2022 · J. Randolph Randolph Hecht, Scott Kopetz, et al. · Journal of Clinical Oncology · 3

491 BASECAMP-1: an observational study to identify relapsed solid tumor patients with human leukocyte antigen (HLA) loss of heterozygosity (LOH) and leukapheresis for future CAR T-cell therapy

2021 · Julian Molina, William Go, et al. · Regular and Young Investigator Award Abstracts · 3

Works count: 2

Citation count: 6

H-index: 2

I10-index: